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Rift Valley fever (RVF) is an important disease threat to animal and human health in most countries in sub-
Saharan Africa. It is caused by the mosquito-borne RVF virus and is associated with major debilitating 
epidemics that occur every 5 to 15 years following periods of above-normal and persistent rainfall. Endemic RVF 
virus transmissions have also been observed in riverine or irrigated areas and forested habitats. Its geographical 
range has slowly expanded from sub-Saharan Africa to the Arabian Peninsula, Madagascar and Mayotte, and 
recent risk analyses suggest there is potential for the disease to spread to temperate regions.  
 
Whereas progress has been made on the development of new RVF control technologies such as vaccines, there is 
lack of knowledge on how these tools should be used at the community level. In East Africa, for instance, 
vaccines are usually administered as part of the emergency response measures following warnings of heightened 
risk of the disease. These emergency vaccination campaigns often fall short of achieving critical levels of 
coverage that are required to establish protective immunity partly because (i) rainfall-driven risk of RVF evolves 
rapidly and, therefore, there is usually not enough time to plan and execute vaccination campaigns and (ii) RVF-
endemic areas get inundated during these periods, limiting their accessibility and hence the distribution of 
vaccines and other humanitarian interventions. 
 
To address some of these challenges, the International Livestock Research Institute (ILRI) is implementing a 
project titled Developing vaccination strategies for Rift Valley fever in East Africa. The project is funded by the United 
States Agency for International Development (USAID)’s Office of U.S. Foreign Disaster Assistance. A two-day 
regional workshop was held on 4–5 October 2017 at the Lake Naivasha Country Club in Naivasha, Kenya to 
introduce the project to the stakeholders and design a framework for RVF vaccination in East Africa. 
 
Workshop purpose and expected outputs 
The purpose of the workshop was to design a framework for RVF vaccination and identify institutions, policies 
and capacities that could be used to support the implementation of the proposed strategies. The expected 
outputs of the workshop were: 
• Project stakeholders sensitized on the RVF risk status in the region and country-level preparedness 
reviewed. 
• RVF vaccination strategies designed and their implementation processes outlined. 
• Institutions, capacities and networks required to implement the vaccination strategies identified. 
 
A total of 27 participants attended the workshop, drawn from the animal and human health sectors in Kenya, 
Uganda and Tanzania; the Food and Agriculture Organization of the United Nations; the Zoonotic Disease Unit, 
Kenya; Wellcome Trust, Kilifi; Washington State University, Kenya program and ILRI among other institutions. 
Iain Wright, ILRI’s Deputy Director General – Research, gave the welcome remarks while Obadiah Njagi, Chief 
Veterinary Officer at the Directorate of Veterinary Services, Kenya delivered the opening remarks. 
 
Workshop presentations 
Three sets of presentations were given on the first day. The first set of presentations gave an overview of the 
project and research activities to investigate immunity dynamics in vaccinated animals, gender and RVF 
vaccination, cost–benefit analyses of alternative vaccination strategies and development of an online platform 
for administering the RVF decision support framework. The second set of presentations reviewed the RVF risk 
status and levels of preparedness in Kenya, Uganda and Tanzania, while the third set covered research on 
development and validation of new RVF vaccines. 
 
Design of RVF vaccination framework and its implementation process 
The workshop identified the need for a regional RVF vaccination framework realising that: 
• RVF is a transboundary animal disease that can easily spread between countries and its epidemics 
evolve rapidly within a short time. 
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• All the East African countries have favourable environments for the disease and often get affected at the 
same time. 
• RVF outbreaks in one country have severe consequences on trade and public health in the entire region 
and beyond. 
• There are opportunities to vaccinate more livestock if vaccination is done at the regional level. 
• The existence of similar production systems across the region makes it possible to disseminate 
messages to all stakeholders. 
• There are opportunities to share local facilities and capacities such as research facilities, vaccine 
production laboratories, standards and guidelines. 
• A regional approach would make it more feasible to stockpile vaccines and develop a vaccine bank. 
• This would facilitate the establishment of cross-regional collaborations to prevent the recurrence of 
outbreaks and boost regional herd immunity. 
• This would provide incentives for the development of a regional risk map for RVF to identify areas of 
high, medium and low risk.  
• A regional approach would strengthen the capacity of stakeholders and veterinary services to prevent 
and control RVF and other priority transboundary animal diseases in the region.  
 
RVF vaccination strategies in livestock  
The following strategies were identified for consideration in formulating an effective RVF vaccination 
framework in East Africa: 
• Routine vaccination in high-risk areas: This should be based on an RVF risk map. However, Uganda, 
unlike the other countries, has not developed an RVF risk map. A harmonized risk map for the region 
will be required to design this strategy. Initial vaccinations should target animals of all ages, after which 
animals not previously vaccinated should be targeted. This, therefore, requires an efficient system of 
animal identification.  
• Vaccination ahead of predicted outbreak: This is a common strategy used in many countries but 
issues that need to be considered to make it more effective include procurement and deployment of 
vaccines and timing of vaccination based on early warning or climate-based predictions. However, the 
sensitivity and accuracy of climate-based predictions in the region is low. It is important to identify the 
required resources and determine how to mobilize them at short notice. 
• Intermittent multi-year vaccination: This could be done once every three years in high-risk areas, 
given that immunity in vaccinated or naturally infected herds declines with time due to population 
turnover. Vaccination can also be targeted at yearlings to maintain about 40% herd immunity and 
minimize costs. 
 
Key assumptions made while determining the alternative RVF vaccination strategies specified above are: 
• Natural infection provides immunity. 
• Immunity is life-long but because of animal population dynamics, it is possible that after three years, 
herd immunity reduces substantially especially for sheep and goats. 
• Only a small proportion of cattle will be naïve three years after 100% vaccination coverage in cattle. 
• Sheep are the most susceptible and pose great risk during epidemics by amplifying transmission of the 
RVF virus. 
• Cattle move more often and farther away compared to sheep and goats. 
• There is need to combine vaccination with livestock identification. 
 
Enabling environment, institutional arrangements and requisite capacities 
The workshop also reviewed institutions, policies and networks that would be required to successfully 
implement the proposed RVF vaccination framework in East Africa. 
• At the Intergovernmental Authority on Development (IGAD) level: IGAD supports the control of 
trade-sensitive diseases in the region, considers RVF to be a priority animal disease and supports 
regional animal health networks. There is, however, a need for a sub-network for RVF formed alongside 
existing networks, promotion of a regional One Health approach and establishment of a strategy to 
control transboundary animal diseases. 
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• At the East African Community (EAC) level:  The EAC recognizes RVF as a priority disease. Policies at 
EAC level exist but their implementation needs to be strengthened. Disease control coordination 
instruments are also in place. These instruments deal with transboundary animal diseases and 
zoonoses. There is a need to establish a zoonotic disease/One Health office and sub-network for RVF. 
• Requisite policies and legal frameworks: There is a need to establish appropriate policies to guide the 
use of vaccines across borders, disease reporting and notification, and standardization. In addition, 
there is a need for appropriate legal frameworks for disease control and vaccination in each country, a 
preparedness and response plan and a memorandum of understanding among member countries. 
There is a need for harmonized disease control policies, legal frameworks and strategies in the East 
Africa region, based on a review of member countries’ existing policies and legal frameworks relevant to 
RVF and other transboundary animal diseases. 
• Policy and legal issues that need to be addressed: The existence of an Animal Disease Act is a useful 
overarching document for each country; harmonized policies for registration of vaccines such as 
Smithburn® and Clone 13 that are already available; a policy for the use of drones to deliver vaccines, 
taking into consideration cost-effectiveness, cold chain and availability of technical staff to implement 
the vaccination after delivery; a policy to address animal identification and traceability; formulation 
and enforcement of relevant laws pertaining to One Health; and policy and legal frameworks related to 
animal movement, and their implications. 
• Other issues that need to be addressed to establish an enabling environment include shortage of 
veterinary services in pastoralist communities; records of where vaccination has already been 
undertaken (because some countries do not have disease control policies); identification of regions at 
risk and development of a regional risk map; and contingency plans for RVF control and enhanced 
funding within countries. 
 
Regarding the support needed to implement an efficient RVF vaccination framework in East Africa, suggestions 
were made on the incentives needed to promote participation by the public and private sectors, the required 






Rift Valley fever (RVF) is an important disease threat to animal and human health in most countries in sub-
Saharan Africa. It is associated with major debilitating epidemics that occur every 5 to 15 years following periods 
of above-normal and persistent rainfall. Endemic RVF virus transmissions have also been observed in riverine or 
irrigated areas and forested habitats. Its geographical range has slowly expanded from sub-Saharan Africa to the 
Arabian Peninsula, Madagascar and Mayotte, and recent risk analyses suggest that there is potential for the 
disease to spread to temperate regions. In East Africa, Kenya and Tanzania often experience a much higher RVF 
burden but recent cases in Uganda (March 2016) indicate that the country is equally susceptible and vulnerable. 
About 50 million people live in the high-risk areas in the East Africa region yet its capacity to implement 
effective RVF prevention and control is low.  
 
Existing options to control RVF in livestock include vaccines, market closure, quarantine and vector control. 
Progress has been made with the development of new RVF vaccines but there is lack of knowledge on how these 
should be used at community level. In East Africa, vaccines are usually administered as part of emergency 
response measures following warnings of heightened disease risk. These emergency vaccination campaigns 
often fall short of achieving critical levels of coverage that are required to establish protective immunity partly 
because (i) rainfall-driven risk of RVF evolves rapidly and, therefore, there is usually not enough time to plan and 
execute vaccination campaigns and (ii) RVF-endemic areas get inundated during these periods, limiting their 
accessibility and hence the distribution of vaccines and other humanitarian interventions. Other challenges 
affecting control of RVF include long inter-epidemic periods, inadequate funding, limited shelf-life of the 
existing vaccines and low uptake of vaccines by livestock producers and other value chain actors. 
 
To address some of these challenges, the International Livestock Research Institute (ILRI) is implementing a 
project titled Developing vaccination strategies for Rift Valley fever in East Africa to support the development of a 
vaccination framework for RVF. The project is funded by the United States Agency for International 
Development (USAID)’s Office of U.S. Foreign Disaster Assistance. The objectives of the project are to:  
• develop more effective RVF vaccination strategies; 
• assess decay rates of RVF-neutralizing antibodies in vaccinated livestock; 
• determine socio-economic and other factors that affect uptake of RVF vaccines; and  
• build capacity among selected livestock value chain actors, including producers and traders. 
 
The project convened a two-day workshop in Naivasha, Kenya on 4–5 October 2017 to introduce its activities to 
various stakeholders and design RVF vaccination strategies. The strategies identified were analysed further to 
identify the optimal option. 
 
Workshop purpose and expected outputs 
The purpose of the workshop was to formulate an appropriate regional RVF vaccination framework and identify 
the institutions, policies and capacities needed to implement the framework. The expected outputs of the 
workshop were: 
• Project stakeholders sensitized on the RVF risk status in the region and country-level preparedness 
reviewed. 
• RVF vaccination strategies designed and their implementation processes outlined.  
• Institutions, capacities and networks required to implement an effective and efficient regional RVF 
vaccination framework identified. 
 
The workshop also provided an excellent opportunity to establish networks among the stakeholders and projects 
undertaking RVF-related activities in the region. A total of 27 participants were in attendance, drawn from the 
animal and human health sectors in Kenya, Uganda and Tanzania; the Food and Agriculture Organization of the 
United Nations (FAO); the Zoonotic Disease Unit, Kenya; Wellcome Trust, Kilifi; Washington State University, 







The workshop was designed as a hands-on activity with a logical combination of plenary presentations and 
discussions, group discussions and feedback sessions. Each group discussion had predetermined terms of 
reference and the groups presented their reports in plenary feedback sessions. This participatory process 
facilitated consensus building and agreement on the issues under discussion. Antony M. Kilewe of Topridas 
Consultancy Services facilitated the workshop, assisted by Violet O. Kirigua. The workshop deliberations were 
guided by the program shown in Annex 2.  
 
Welcome remarks 
Antony M. Kilewe, Topridas Consultancy Services 
The facilitator began by leading the participants on self-introduction before inviting Bernard Bett from ILRI to 
give his introductory remarks. Dr Bett welcomed the participants and thanked them for making time to attend 
the workshop to discuss the RVF project being led by ILRI. He then outlined the workshop’s purpose and 
expected outputs, after which he delivered the welcome remarks by Iain Wright, ILRI’s Deputy Director 
General–Research, who had sent apologies for not being able to attend the workshop. 
 
Iain Wright, Deputy Director General–Research, ILRI 
In highlighting the objectives of the workshop, he noted that the participants were drawn from all the countries 
in East Africa targeted by the project. ILRI’s previous projects on RVF, such as those that have developed RVF risk 
maps and decision support frameworks, have been implemented in the entire East Africa region, given that RVF-
endemic sites traverse international borders. He noted that the participants represented a range of disciplines 
required to develop sustainable One Health programs and institutions to manage and control zoonotic diseases 
in the region. He noted this was a very important workshop aimed at addressing key challenges associated with 
control of RVF in the region. He thanked all for attending the workshop and said he looked forward to receiving 
the report of the proceedings. 
 
Opening remarks 
Obadiah Njagi, Chief Veterinary Officer, Directorate of Veterinary Services (DVS), Kenya 
He welcomed the workshop participants to Naivasha, noting that RVF was not a new disease, having been 
reported in the Rift Valley. It was thus appropriate that discussions on RVF were being held in Naivasha, which 
is on the floor of the Rift Valley. He said Kenya has experienced RVF outbreaks since the 1990s during which 
time he worked in the laboratory handling infected animals and even once got infected with RVF. The 2006–07 
outbreak affected Kenya, Uganda and Tanzania. Outbreaks can initially be explosive and are usually associated 
with unusual weather patterns and the dynamic environment in which livestock-keepers raise their animals.  
 
During the 2006–07 outbreak, two main regions in Kenya (Western and Nyanza) were not affected, the reasons 
for which are not yet understood; research on this will improve our understanding of the mitigating factors. In 
Kenya, the 2006–07 outbreak resulted in 700 human cases and 158 deaths and the economic cost to the country 
was 2.1 billion Kenya shillings (KES). This calls for adequate planning and preparedness to manage outbreaks 
and requires commitment from all relevant institutions. The DVS and the Ministry of Health, through the 
Zoonotic Disease Unit’s technical working group, set out to meet international health regulation obligations of 
2005 to protect local communities from the adverse effects of disease outbreaks. In 2010, the group developed 
the country’s preparedness and contingency plan and adopted the One Health approach in the management of 
RVF. The implementation of the plan has improved the efficiency and effectiveness of RVF management.  
 
Vaccination has been the main intervention in response to RVF outbreaks. The main vaccine that has been 
successfully used is the Smithburn® vaccine, despite its shortcomings. Other vaccines such as Clone 13 are still 
under development. Vaccination is usually done during periods of heavy rainfall but access to animals is 
normally hampered by poor road conditions and exacerbated by limited quantities of the vaccines. Kenya has 
had to call on development partners for assistance, but the desired coverage has not been attained. The DVS is 
glad to be associated with the project and is committed to supporting its implementation which will provide 
useful insights in the management of RVF. Dr Njagi thanked the development partners that had assisted in the 
management of RVF in the past and the participants for finding time to attend the workshop and wished them 
fruitful deliberations. He then declared the workshop open.  
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Project strategic focus and implementation 
arrangements 
 
This session featured presentations on the project activities and implementation arrangements followed by 
plenary discussions. All the presentations from the session can be accessed from the following link: 
https://www.dropbox.com/sh/wkg3wfrgmdiy2tq/AABkzq68x-QzGoHYEE7xmhyua?dl=0. 
 
Overview of the project 
Bernard Bett 
The project is two-year activity that was expected to start in February 2017. However, due to the election process 
in Kenya, there was a delay in implementation and the project only begun in October. The aim of the project is to 
determine how RVF vaccines can be used more effectively. 
 
In East Africa, RVF outbreaks often occur following periods of heavy and persistent rainfall lasting 2–3 months. It 
is often difficult to plan effectively for such events, given that the risk evolves rapidly over a short time. 
Published research suggests that livestock vaccination is a major intervention that can be used for both 
preventive and control purposes. However, there are no guidelines on how to use these vaccines at the 
community level. Given that vaccination provides long-term immunity, it might be practical to vaccinate 
animals when they are still young to build a solid herd immunity over time as is done for East Coast fever. 
However, for RVF, there is a huge economic implication of vaccinating livestock over the inter-epidemic period 
when there is no risk. These are some of the issues the project aims to analyse. 
 
Humans often act as sentinels for RVF, given that surveillance systems for the disease are generally unreliable. 
In this case, official responses are often implemented when human cases have been reported in hospitals. The 
lack of response during peace-time periods is partly due to lack of data that can be used to quantify the economic 
benefits of routine vaccination. Although major RVF vaccination campaigns are often implemented as a 
publicly-funded service, private ranches in endemic areas are slowly getting engaged through their own 
vaccination campaigns. However, willingness to pay and acceptable levels of vaccination have not been assessed 
and it is not clear whether such efforts can lead to the required vaccination coverage. There are also no 
structures and guidelines on how this should be undertaken to avoid patchy distribution of the vaccine. The 
project objectives that aim at addressing some of these issues include: 
• Using mathematical modelling to identify the optimal vaccination strategy for the region. 
• Refining the decision support framework to guide RVF vaccination. 
• Studying immunity dynamics in livestock in endemic areas to understand how livestock offtake affects 
the longevity of herd immunity. 
• Building capacity in livestock identification and vaccination at the community level. 
• Carrying out studies on gender and socio-economics to identify factors that affect uptake of vaccination. 
 
Immune response studies (field and laboratory) 
Nicholas Svitek 
This presentation outlined the objectives of the first study on immunity dynamics of RVF in vaccinated animals. 
The study will assess the longevity of RVF immunity in vaccinated animals based on the levels of neutralizing 
RVF virus antibodies in circulation. It will use a longitudinal design involving cattle, sheep and goats vaccinated 
with the Smithburn® vaccine. The laboratory component will investigate the decay rates of neutralizing 
immunoglobulin G (IgG) antibodies using enzyme-linked immunosorbent assay and virus neutralization tests. 
 
Gender and RVF vaccination 
Salome Bukachi 
This presentation covered gender and socio-economic factors that influence the use of RVF vaccines in livestock. 
Very few studies have been carried out to identify socio-economic factors that affect the delivery of livestock 
vaccines. Livestock production is often a shared household responsibility, with men more focused on disease 
management and women engaged in care of sick animals. Gender and socio-economic differentials are based on 
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access to and control and management of livestock products. In many areas, the government implements RVF 
vaccination campaigns with minimal involvement of livestock producers who play a more critical role in 
bringing their animals for vaccination.  
 
The specific objectives of the study were to: 
• assess how household decision-making patterns affect access to, control and use of, and responsibility 
for animal health interventions including RVF vaccines; 
• examine how information on vaccination is disseminated and how motivation for engagement in 
vaccination is achieved, by gender and other socio-economic characteristics; 
• establish perceptions on preventive versus curative services among men and women; and 
• assess how vaccine delivery systems affect community-level uptake of RVF vaccines. 
 
It was suggested that the study sites be grouped into two: RVF-endemic sites with frequent vaccination (Baringo, 
Kenya) and RVF-endemic sites with no history of vaccination (Kabale, Uganda). It will be a qualitative study that 
will include 20 focus group discussions, half of which will be for men only and the other half for women only. 
Each group will consist of 8–12 participants. Key informant interviews will be conducted with veterinary and 
medical officials and prominent community members to triangulate information. The themes to be explored 
include key livelihood activities in the village, livestock species kept, livestock diseases and their impacts, 
investments in disease control and decision-making at the household level, livestock vaccination campaigns on 
RVF, proportion of animals covered in the recent campaigns (proportional piling), factors that affect uptake, and 
household decision-making on RVF control/vaccination. 
 
Application of cost-benefit analysis to assess the economic viability of 
transboundary animal disease control strategies 
Francis Wanyoike 
The economic feasibility of a livestock disease control strategy is a major consideration for a public institution 
that must justify the use of public resources, a funding agency that seeks to support a disease control program or 
a private company/individual farmer faced with a decision on whether to invest in a disease control strategy or 
to comply with government regulations. Cost-benefit analysis is one of the methods used to estimate the 
economic feasibility of an investment when both the benefits (positive economic impacts) and costs (negative 
economic impacts) are estimated in monetary terms. An economically viable initiative is one in which the 
benefits are at least equal to or greater than the costs. 
 
Costs and benefits of transboundary animal disease prevention and control interventions were classified as 
those within or beyond the livestock sector. Benefits within the sector include increased asset and output value, 
reduced prevention and treatment costs and reduced cost of outbreak control. Costs within the sector are related 
to prevention and preparedness, outbreak control and changes to management or production systems. Benefits 
beyond the livestock sector include human lives saved or quality-life years increased and reduced cost of public 
health treatment. Costs beyond the livestock sector include public health investments, higher food prices for 
consumers and costs to tourism and wildlife. The most obvious benefits from controlling a transboundary 
animal disease result from reduced disease incidence in a system, allowing livestock owners to consume and/or 
sell more in new markets. It was suggested that this framework be used to evaluate the costs and benefits of the 
alternative RVF vaccination strategies proposed in the workshop. 
 
RVF decision support framework 
Absolomon Kihara 
This presentation provided an insight into ongoing work on the development of an online portal to administer 
the RVF decision support framework. This will enable dynamically generated real-time RVF risk maps that are 
linked to the decision support framework showing RVF risk estimate at region, country, county or division levels 
for localized decision-making. The system will use rainfall and flood dynamics to estimate RVF risk over time. 
The tool will be accessible from a public website and preferably hosted on a government website. Significant 
progress has been made to improve the tool. The next steps include developing a program to automatically fetch 
rainfall forecasts, refining the RVF model, dynamically linking risk to the decision support framework and 




Plenary discussion of the presentations 
Question: What is the minimal time of protection following RVF vaccination? 
Answer: Data from previous studies show that this can last up to a year, but other studies suggest lifetime 
immunity. 
 
Q: Baringo may not be representative of high risk in terms of animal husbandry. Could the project widen the 
scope to include Tana River, highland areas of Murang’a and high-rainfall areas of the Rift Valley to 
accommodate the varied agro-ecological zones as well as different animals?  
A: Initially, the project targeted Baringo, Isiolo and Garissa but due to logistical aspects some sites were dropped. 
However, this is still under discussion and will be concluded. 
 
Q: On cost-benefit analysis, I did not see much on the effects of abortions on production (reduced milk 
production, weight gain etc.). 
A: The presentation on economic analysis was a general presentation but it did state that among the benefits of 
vaccination would be increased assets and outputs. These imply the products (e.g. milk) that accrue from the 
increased benefits and are captured by the word ‘outputs’. 
 
Q: Regarding the project sites, would it be possible to consider Tanzania because it has been severely infected in 
the past, for example, in areas around Iringa? 
A: Tanzania was initially in the proposal. ILRI could advise on the status. 
A: The sites to be incorporated in the project have not been concluded. There is need to develop criteria for 
selecting the sites and the workshop could probably advise on the selection criteria. 
 
Q: How easy is it to quantify the costs and benefits beyond the livestock sector? 
A: Systems modelling tools, such as Policy Analysis Matrix, could be used. 
 
Q: What are the residual effects of the vaccine on consumers, given that it confers long-term immunity to the 
animals?  
A: The immunity developed by the animals is sterile immunity and, therefore, the Smithburn® vaccine is not 
transferrable to humans. 
 
Q: To help the uptake of vaccines, it has been suggested that it may be necessary to combine the vaccines into 
multivalent products to make them cost effective. Single vaccines may not be relevant to different communities. 
However, multivalent vaccines have the potential to increase uptake. Is the project developing recombinant 
vaccines? 
A: This is an important point, particularly for ILRI as it works on vaccines. This is not within the scope of the 
project.  There are tools in social science (e.g. contingent variation) that use hypothetical scenarios to evaluate 
the uptake of a product yet to reach the market. We plan to use these tools to evaluate the acceptability of such a 
product although it has not been made available in the market. 
A: A recombinant vaccine strategy would have implications on costs and benefits. The hypothesis is that there 
would be significant benefits and we hope to generate data that could influence demand for such products. 
 
Q: Will the project use sentinel herds? Where will the animals be sourced? 
A: The project will use community herds in endemic areas and not sentinel herds. There is a similar project that 
will be implemented in collaboration with ILRI in Kapiti which will use sentinel herds. It will be possible to 
compare the findings of these two projects.  
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Background review of RVF control policies in East Africa 
and vaccine development 
 
In this session, presentations were made on the status of RVF and the control measures used in Kenya, Uganda 
and Tanzania. The presentations also covered challenges and opportunities associated with RVF control, and 
experiences and lessons learnt in the management of RVF in the region. The presentations were followed by 
plenary discussions. All the presentations made during this session can be accessed from  
https://www.dropbox.com/sh/wkg3wfrgmdiy2tq/AABkzq68x-QzGoHYEE7xmhyua?dl=0  
 
History of RVF in Kenya 
Harry Oyas 
The first case of RVF was reported in Kenya’s Rift Valley in 1912 and subsequent outbreaks have occurred at 
intervals of 5 to 15 years. The last major outbreak in Kenya occurred in 2006–07 during which 158 people died 
and the country experienced losses amounting to KES 4 billion. The outbreak impacted heavily on local, regional 
and international trade in livestock and livestock products. 
 
Kenya has developed an RVF control strategy contained in the country’s RVF contingency plan. The objectives of 
the plan are to (i) serve as a national reference tool for RVF outbreak preparedness and response, (ii) provide 
information on risk and disease hotspots in the country, (iii) provide information on actions to be taken during 
the different phases of the outbreak response, (iv) define the coordination structures, including the Ministry of 
Health, the Ministry of Agriculture, Livestock and Fisheries and other agencies and (v) identify needs and 
facilitate the mobilization of resources for response.  
 
Regarding RVF surveillance in Kenya, two approaches have been adopted: 
• The use of sentinel surveillance in Machakos, Bachuma, Naivasha and Trans Nzoia where flocks of 
naïve sheep and goats are tested during high-risk periods. The sentinel herd is sampled before the onset 
of the rains and thereafter every four weeks during the rainy season until the end of the rains. 
• Syndromic surveillance conducted during high-risk periods. Livestock owners are recruited to report on 
syndromes encountered as well as weather conditions. The Kenya Livestock Wildlife Syndromic 
Surveillance System has been developed as an offshoot. 
 
Control measures adopted include awareness creation, vaccination during alert periods, movement control 
(quarantine), market closures and vector control. In addition, routine annual vaccination is conducted in high-
risk districts. In other instances, vaccination is done ahead of predicted outbreaks and in low-risk areas during 
localized outbreaks. Animals for export are vaccinated 21 days before export. As a policy, vaccination is not 
allowed in areas or flocks confirmed to be affected during an RVF outbreak. 
 
RVF situational assessment in Uganda 
Dan Tumusiime and Josephine Namayanja 
In 2012, the Government of Uganda embarked on preparing guidelines for RVF surveillance. The initial steps 
involved serosurveys which revealed the presence of RVF in the country. The first RVF outbreak in the country 
occurred in March 2016 in Kabale District, western Uganda after the Ministry of Health confirmed on 11 March 
2016 that two patients had tested positive for RVF. Management of the human cases was good. 
 
Control measures included surveillance and reporting, disease investigation, movement control, awareness 
creation and regulatory framework and coordination. To enhance coordination, a multi-sector national task 
force and national and district rapid response teams were reactivated. Members of the national task force 
include the Ministry of Agriculture, Animal Industry and Fisheries; the Ministry of Health; the Ministry of Water 
and Environment; the Uganda Wildlife Authority and partners including the World Health Organization 
(WHO), Centers for Disease Control and Prevention (CDC), FAO and UNICEF. The Animal Diseases Control Act 
(1964) does not include RVF in the list of diseases to be controlled. The Ministry of Agriculture, Animal Industry 
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and Fisheries has developed a statutory instrument for RVF that is awaiting approval. However, there is a multi-
sector RVF contingency plan in place.  
 
Uganda has intensified passive and active surveillance through outbreak investigations and entomological 
surveys. Sampling usually starts from the high-risk areas, including abattoirs, households where human cases 
have been reported and livestock markets. Upon positive identification of RVF, the Director of Animal Resources 
and the Director General of Health Services hold a joint press briefing.  
 
RVF outbreak in Tanzania 
Fausta Mosha 
Tanzania reported its first outbreak of RVF in livestock in 1930. Thereafter, outbreak waves of varying magnitude 
and in different locations have been reported, with an average inter-epidemic period of 7.9 years (range 3–17 
years). The country’s first documented outbreak of RVF in humans was in 1977. Major outbreaks also occurred in 
1997–98 during the El Niño floods. The second major outbreak occurred in 2006–07 after the heavy El Niño-
associated rains; this epidemic represented the largest ever reported outbreak of RVF in Tanzania: 309 suspected 
cases, 186 (60%) RVF-positive and 144 deaths (case fatality ratio 47%).  
 
Among the actions taken to contain the disease were active intensification of surveillance, training workshops 
in all affected regions, health education campaigns and vaccination of livestock. Tanzania also formed a multi-
sector RVF task force to oversee the outbreak. Medical and laboratory supplies were distributed to the affected 
areas and laboratory capacity strengthened. The presentation also outlined the distribution of RVF in Tanzania, 
strategies for mitigation and lessons learnt in the management of RVF. 
 
Tanzania has developed a national RVF emergency preparedness and response plan which has the following six 
intervention areas: 
• Improving institutional capacity for early detection and reporting 
• Improving the implementation, management and coordination of the plan 
• Maintaining business continuity during different phases of an epidemic 
• Preventing and controlling RVF infections in humans and animals 
• Increasing immunity of animals to RVF 
• Monitoring and evaluation of the implementation of the plan 
 
FAO’s RVF-related activities in the region 
Sam Okuthe and Joseph Njuguna  
Past interventions include prevention and control in the livestock sector, joint RVF preparedness assessment in 
Kenya and Tanzania, collaborative international engagement to prevent and mitigate threats from pathogens in 
targeted East African countries, and rapid qualitative risk assessment and surveillance in Uganda. Current 
interventions include ongoing capacity building on priority zoonotic diseases and management of influenza A 
viruses and other high-impact diseases.  
 
A One Health approach and multi-sectoral engagement involved the national and county governments and 
partners from the animal and public health sectors. FAO was involved in the review, update and dissemination 
of the RVF contingency plan and decision support framework, and supported the development of Standard 
Operating Procedures. The outcomes of the joint RVF risk assessment included better preparedness in terms of 
training and better awareness creation than during the 2006–07 outbreak.  
 
The outcomes of a collaborative project include strengthened capacity of target countries for risk-based disease 
surveillance; production and dissemination of a disease investigation and laboratory manual; improved 
diagnostic capacity of central veterinary laboratories in Ethiopia, Kenya, Tanzania and Uganda and enhanced 
capacity of field veterinarians to prepare for and respond to animal disease emergencies.  
 
National and sub-national veterinary staff have been trained on syndromic surveillance and outbreak 
investigations to support surveillance for RVF and other priority zoonotic diseases. In Kenya, support has been 
provided for livestock sentinel surveillance for RVF sentinel herds in Machakos, Naivasha, Bachuma and Japata. 
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In Ethiopia, there is a risk-based surveillance plan for RVF within the national contingency plan and 
strengthened surveillance through two systems that include RVF as a reportable disease. In Uganda and 
Tanzania, RVF surveillance has been strengthened through an Event Mobile Application system with RVF as a 
priority disease. Other activities include strengthening of laboratory systems; development of biosecurity and 
biosafety and workforce; training on good emergency management practice; and enhancing preparedness, 
detection, response and recovery. 
 
RVF control options 
Kariuki Njenga 
RVF is endemic in eastern Africa and all countries in the region have experienced outbreaks mainly in north 
Sudan, western and southern Somalia, northern Tanzania, and eastern and southern Kenya. There are five key 
recommended control options: livestock vaccination, public education, slaughtering ban, livestock quarantine 
and vector control. The most effective control measures are livestock vaccination, public education and 
slaughtering ban. Vector control, though recommended, is largely ineffective and most countries shy away from 
the cost of implementing it. 
 
There are two main vaccines used to control RVF. The most common is the Smithburn® vaccine that is currently 
licensed in Kenya and Tanzania and produced at the Kenya Veterinary Vaccines Production Institute 
(KEVEVAPI). The other, which is more recent and licensed in South Africa and Namibia, is the RVF Clone 13. The 
Smithburn® vaccine has been reported to have some side effects such as abortions and thus many livestock 
farmers in the ranches tend to avoid using it. Trials carried out in Kapiti and Kiboko have shown that Clone 13 
has fewer side effects. Some of the strategies that have been adopted in control of RVF are (i) yearly vaccination, 
an excellent policy but the cost is prohibitive and achieving coverage is a challenge; (ii) intermittent multi-year 
vaccination which is done periodically and is more cost effective and (iii) use of a multivalent or combination 
vaccine consisting of an RVF antigen and an antigen of a vaccine which is likely to be used regularly and is cost 
effective. 
 
Vaccines are unstable and, therefore, produced in low quantities for immediate use at a specific time. Setting up 
a regional vaccine bank would make the vaccine available following disease outbreaks. Most experts agree that 
an effective livestock vaccination program can significantly mitigate or even prevent any RVF outbreak.  
Unfortunately, no country in the greater Horn of Africa has an RVF livestock vaccination policy, partly because of 
the long inter-epizootic periods of up to 10 years. 
 
Development of new vaccines 
Madeleine Clark and George Warimwe 
The presentation was based on the co-development of a human and animal vaccine using the ChAdOx1 RVF 
vaccine which can be used in all species affected by RVF. RVF is a multi-species virus that affects cattle, sheep 
goats, camels and humans. The current research is looking for a vaccine that can target all vulnerable species. 
The current licensed inactivated and live RVF virus vaccines are only suitable for use in livestock, and there are 
no licensed vaccines for humans. The project is in the process of conducting a non-inferiority trial in target 
animals in the field. This will be validated in four animal species for vaccine-induced immune response. 
 
Madeleine also presented the vaccine development plan. The ChAdOx1 vector was selected due to its inherent 
stable and safe characteristics (It has been used successfully in several animal and human vaccine candidates). 
Product development has been initiated in collaboration with Oxford University that has an excellent facility for 
the development of viral vectors. The project has received funding for livestock field trials in sheep, goats, cattle 
and camels in Kenya and human phase 1 clinical trials in healthy adults in the United Kingdom and Uganda.  
 
Plenary discussion of the presentations 
Question: Reference is made to Uganda’s presentation and the slide on anti-RVF virus IgG detection results. 
Was this from the same animals?  




Q: Studies have shown that RVF is caused by different strains and epicentres. Do the available vaccines protect 
against all the strains and animals? Are these variables expected to affect vaccination strategies? 
A: Previous work by CDC on gene sequencing showed the differences in RVF virus are at the level of amino acid 
sequences and not profound to affect the effectiveness of vaccines. We, therefore, believe one vaccine should be 
able to control all the strains. Any vaccines developed should be able to contain the disease across the region. 
 
Q: Reference is made to the point that vaccination should not be done among infected animals.  But if you 
provide only 100,000 doses in the event of an outbreak, will you vaccinate healthy animals or those already 
showing signs of infection? We always advise officers that they should try to contain an outbreak. We 
understand the justification for not vaccinating infected animals but when inadequate doses of vaccines are 
provided, how can vaccines be distributed effectively on the ground? 
A: Based on the presentation from Uganda on flooding and stagnant water, we probably need to reconsider the 
approach we use for risk mapping. We have been focusing on rainfall intensity and, therefore, might have missed 
some of the high-risk areas. We need to consider how to capture floods and their duration of persistence. This 
will probably require better approaches such as topography and surface run-off, but we haven’t done that yet. 
 
Q: Studies on Clone 13 have not conclusively stated the duration of immunity in vaccinated animals. For how 
long does the vaccine provide protection? How long should the interval of vaccinations be, especially for small 
stock? Waiting for alerts is not the best approach. 
A: We did the study for up to one year and animals tested at the end of the period still had protective antibodies. 
This shows that these animals were immunized over the study period. The animals were, however, not exposed 




Design of RVF vaccination strategies and their 
implementation processes 
 
The design of RVF vaccination strategies and their implementation processes was carried out in three discussion 
groups. While carrying out their respective assignments, the groups were expected to refer to the plenary 
presentations and discussions, any other relevant documents as well as their collective knowledge and 
experience. The following questions guided the group discussions: 
• What are the compelling purpose and objectives of a regional approach to RVF vaccination in East 
Africa?  
• Given the overall purpose and objectives of a regional approach to RVF vaccination in East Africa, 
identify and design at least three alternative RVF vaccination strategies in livestock. (Some of the 
issues to consider in the design of vaccination strategies are the timing of vaccination, targeted areas, 
and species or ages of animals to vaccinate). 
• Given the designed RVF vaccination strategies in livestock, outline the appropriate processes required 
for their effective implementation. 
• What are the major elements or aspects that should be considered in the formulation of an effective 
and efficient RVF vaccination framework in East Africa? 
• What are the anticipated challenges and opportunities in the design, adoption and implementation of 
an effective and efficient RVF vaccination framework in East Africa? 
 
After the deliberations, reports from the three groups were presented and discussed in plenary. Since the three 
groups responded to the same guiding questions, their reports were then harmonized and summarized into one 
report that incorporates the plenary feedback outlined below. 
 
Purpose and objectives of a regional approach to RVF vaccination 
The following were indicated as the rationale for a regional approach to RVF vaccination in East Africa:  
• Transboundary nature of the disease: Being a transboundary animal disease, RVF poses significant 
economic, trade and/or food security challenges in several countries and can easily spread from one 
country to another and evolve rapidly into major epidemics. Therefore, the control and management of 
the disease, including exclusion, requires cooperation between neighbouring countries. 
• Common conducive environmental conditions for outbreaks and similar ecosystem: RVF 
outbreaks have been associated with periods of widespread and above-normal rainfall over several 
months. All countries in East Africa can experience these conditions at the same time. 
• Consequences of the outbreak affect trade partners and public health in the region: RVF leads to 
trade bans on the infected country, causing significant economic losses. The zoonotic nature of RVF 
leads to serious public health problems.  
• Greater impact as compared to individual countries: Greater numbers of livestock would be 
vaccinated if vaccination were done at regional level. 
• Similar production systems: The existence of similar production systems across the region makes it 
possible to pass messages to all stakeholders. 
• Facilitation of sharing of local facilities within the region: A regional approach would make it 
possible for countries to share and effectively utilize local laboratories, vaccine laboratories, standards 
and guidelines, among other facilities. 
• Stockpiling and storage of vaccines: A regional approach would make it viable to have a vaccine bank 
in the region. Vaccines stored in one country should not go to waste and should be made available in 
another country in the event of an outbreak there. 
• Establishment of cross-regional collaborations: A regional approach will facilitate the establishment 
of cross-regional collaborations to prevent the recurrence of outbreaks and boost regional herd 
immunity. 
• Facilitation of the development of one regional risk map: A regional approach will facilitate the 
development of one regional risk map for RVF to identify areas of high, medium and low risk. Currently, 




In view of the above considerations, the overall purpose of a regional approach to RVF vaccination in East Africa 
should, therefore, be to: 
• facilitate the establishment of cross-regional collaborations to prevent the recurrence of outbreaks and 
boost regional herd immunity;  
• strengthen the capacity of stakeholders and veterinary services to prevent and control RVF and other 
priority transboundary animal diseases in the region; and  
• improve the management, prevention and control of RVF and other priority transboundary animal 
diseases in the region.  
 
Given the overall purpose, the objectives of a regional approach to RVF vaccination in East Africa are to: 
• take advantage of economies of scale and enhance impact through sharing of facilities for vaccine 
production, vaccination, research, laboratories and technical expertise; 
• minimize the regional impact of RVF by reinforcing veterinary services in the region; 
• harmonize and ensure effective coordination of RVF vaccination activities among countries in the 
region; 
• improve the quality and efficiency of RVF vaccination through a structured and scientific approach; 
• sustain RVF control measures to ensure accessibility to external livestock and livestock product 
markets; and 
• improve the overall health of livestock in the region by reducing the impact of RVF and other priority 
animal diseases. 
 
RVF vaccination strategies in livestock  
The following were identified as some of the general vaccination issues to consider: 
• Period of immunity in animals after vaccination, assuming lifelong protection: the lifespan of cattle is 
4–5 years, sheep and goats 1–2 years and camels 15–25 years. 
• The main variant is at herd level; newborns and new recruits will be susceptible. 
• The cost of vaccine delivery is higher than that of the vaccine itself. For example, the Smithburn® 
vaccine costs KES 12 per dose. 
• Deliver the vaccine when it is logistically convenient. 
• Identification of animals is an issue to consider. 
• During peace time, vaccine stocks should be available. 
• There is need to identify a regional coordination body, funded by all countries involved, to drive RVF 
activities. 
 
The following alternative RVF vaccination strategies in livestock were identified for consideration in the 
formulation of an effective and efficient RVF vaccination framework in East Africa (see summary in Table 1): 
• Routine vaccination in high-risk areas (yearly): This should be based on an RVF risk map. However, 
only Kenya and Tanzania have risk maps; the other countries need to develop theirs. Routine 
vaccination should target all animals of all ages (without maternal antibodies). Subsequent vaccination 
should target animals that were not vaccinated (yearlings); consider animal identification. 
• Vaccination ahead of a predicted outbreak (during alert/emergency): Issues to consider include 
deployment, procurement of vaccines and timing between climate predictions. However, the sensitivity 
and accuracy of climate predictions in the region are low. It is important to know where resources are 
and how to mobilize them at short notice. 
• Intermittent multi-year vaccination: This should be carried out once every three years in high-risk 
areas because immunity is approximately three years. Only yearlings should be vaccinated and a herd 




Table 1: Summary of the vaccination strategies 
Time Vaccination strategy Assumptions 
Routine vaccination (yearly) Intermittent multi-year 
vaccination 
Vaccination ahead of 
predicted outbreak  
(during alert/emergency) 
Peace time Timing  
During the wet season when 
animals are in good condition.  
During the dry season, animals 
are usually scattered and have 
poor body condition, raising 
questions about their response 
to vaccination. Uptake studies 
are, therefore, needed in 
different seasons. 
Timing is also affected by 
season and production system.  
 
Target areas 
Target high-risk areas and 
consider vulnerability.  
Within high-risk areas, there 
are also more vulnerable areas. 
Areas with constant exposure 
have protective cover. 
Consider the gender and socio-
cultural and economic 
dynamics of target 
communities.  
 
Target species  
Cattle, sheep, goats and camels 
Cattle have higher 
seropositivity while small 
ruminants have high mortality 
rate. 
Identify vaccinated animals to 
avoid repeats and unnecessary 
costs. 
 
Age of animals to vaccinate  
Target animals of a specific age 
(6–18 months for cattle; 6–12 
months for sheep and goats).  
RVF maternal antibodies 
should guide on age. 
Maternal immunity lasts up to 
the first six months of life. 
Timing 
Every three years but 
interrupted if there is an alert. 
Consider turnover rate which 




Vaccinate in medium-risk 




Cattle and camels but spaced 
every three years. 
Small ruminants can be 
vaccinated annually because 
of high turnover rate. 
There is a challenge of 
separating the species. 
Timing 




Localized vaccination.  
Depending on production 
systems, determine how far 
to go from the index case.  
Delineate the area and 
carry out rapid assessment 




All animals at risk 





Only a small 
proportion of cattle 
will be naïve three 
years after 100% 
vaccination coverage. 
After three years, all 
sheep will be naïve. 
Sheep are the most 
susceptible and pose 
great risk to the public. 
Cattle move more 
often and farther than 
sheep and goats. 
Immunity is lifelong. 














Vaccination moved to medium-
risk areas with the assumption 
that the high-risk areas are well 
covered.  
Carry out a risk assessment in 
high-risk areas while covering 
medium-risk areas.  
Consider all animals. 
No vaccination Emergency vaccination 
Delineate the area and 
vaccinate 
 
Outbreak  No vaccination No vaccination Vaccinate uninfected 
animals that have potential 
of getting infected 
Avoid in areas of outbreak 






Aspects to consider in the process of implementation of a sustainable RVF 
vaccination framework 
• Setting up of a regional coordination body to drive the implementation of the RVF vaccination 
framework. 
• East African Community (EAC) ministries, in close collaboration with the relevant livestock and human 
health ministries, could be lobbied to source for funding for the coordination body and ensure the 
purpose and objectives of the regional approach to the control of RVF are achieved. 
• Strengthening of country and regional weather forecasts, climate studies and information sharing. 
• Lobbying and advocacy for the formulation of appropriate policies and legal frameworks to support the 
implementation and sustainability of the RVF vaccination framework. 
• Lobbying and advocacy for registration of at least one RVF vaccine in each of the countries at risk. 
• Advocacy and sensitization for buy-in from all livestock value chain actors, including policymakers, 
using communication strategies that take into consideration gender and socio-cultural and economic 
factors.  
• Assessment and development of capacities at all levels. 
• Supporting and facilitating the development of appropriate vaccination plans and effective monitoring 
and evaluation systems. 
• Assessment of the available infrastructure and establishment of appropriate sharing mechanisms. 
• Establishment of appropriate mechanisms to ensure sustainability, including reducing costs, exploring 
the possibility of recombinant vaccines, sharing the cost of vaccine delivery between the government 
and producers, and public-private partnerships. 
 
Aspects to consider in the formulation of an effective and efficient regional RVF 
vaccination framework 
• Coordination within countries (including the relevant sectors such as finance, education, security and 
disaster preparedness) and between countries.  
• Vaccine availability, sourcing, delivery and affordability, including the possibility of establishing a 
regional vaccine bank. 
• Targeted research to understand the disease epidemiology and to develop appropriate vaccines, 
including multivalent or combination vaccines.  
• Information gathering, dissemination and sharing to inform decision-making processes. 
• Consideration of risks in different regions and development of regional risk maps. 
• Existence of different policies and legal frameworks in each of the countries and consideration of 
possible harmonization. 
• Socio-economic and gender considerations and understanding of the impact of RVF within and across 
countries. 
• Ensuring political goodwill to avoid conflict and political instability. 
• Publicity and awareness creation. 
• Capacities of the national and regional veterinary services in terms of financial and human resources 
and infrastructural facilities. 
• Individual and joint country mobilization of resources to implement the RVF vaccination framework. 
• In-country and regional monitoring, evaluation and sharing of lessons and experiences. 
 
Challenges and opportunities in the design, adoption and implementation of an 
effective and efficient regional RVF vaccination framework 
Challenges 
• Inadequate financial and human resources due to competing priorities. 
• Inadequate stocks of RVF vaccine, side effects of the vaccine and low uptake, which call for the 
development of a multivalent vaccine. 
• Limited lead time to prepare and mobilize resources after an alert is issued. 
• Insufficient data to support modelling of, for example, protection level and minimum number of 
animals to vaccinate to ensure herd immunity. 
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• Inadequate core infrastructure such as storage facilities, equipment, roads, telephone network and 
electricity, and insecurity in high-risk areas. 
• Poor livestock identification and traceability systems and lack of a ‘Differentiating Infected from 
Vaccinated Animals’ strategy. 
• Overlooking of the gender, socio-cultural and economic dynamics of communities in major decision-
making. 
• Weak animal health services sector and inaccurate prediction of outbreaks. 
• Weak inter-government collaboration and cross-border monitoring of animal movement and vaccine 
uptake. 
• Low sensitivity and accuracy of climate predictions in the region. 
 
Opportunities 
• Availability of multi-disciplinary expertise to develop a combination vaccine and other novel, safer 
vaccines. 
• Existence of veterinary systems, an animal health desk at the EAC and availability of technical and 
support experts in governments. 
• Possibility to carry out RVF vaccination during routine vaccination for other diseases. 
• Existence of regional health networks such as the East African Public Health Network (human disease 
surveillance) and the Veterinary Epidemiology Network, including proximity to the Pan-African 
Veterinary Vaccine Centre (PANVAC) and Africa CDC. 
• Existence of political goodwill and regional economic communities such as the EAC, the 
Intergovernmental Authority on Development (IGAD) and the Common Market for Eastern and 
Southern Africa. 
• Presence of and close liaison with international technical organizations and institutes such as the 
African Union–Interafrican Bureau for Animal Resources (AU-IBAR), CDC, FAO, the World Organisation 
for Animal Health (OIE) and WHO. 
• Existence of established institutions of research and higher learning. 
• Established reference laboratories such as the Kenya Medical Research Institute (KEMRI) and the 
Uganda Virus Research Institute. 
• Recognition of RVF as a priority zoonotic disease in the region and availability of vaccines, including 
Clone 13. 
• Possibility of adapting the contingency plans available in some countries for use in other countries that 
are yet to develop and implement theirs. 
 
Plenary discussion of the group reports 
Comments 
• What is the opportunity for delivery of vaccines using mobile phones, particularly in remote areas? 
Some scientists are interested in using drones for delivery of vaccines and these are new opportunities. 
Community animal health services were used successfully in the management of rinderpest, showing 
how veterinary services can be effective particularly over large areas. There is a need to scan the 
innovations around animal health. The current global push to eradicate peste des petits ruminants 
(sheep and goat plague) is receiving a lot of funding and could be an opportunity for more funding for 
RVF prevention and control. 
• Interconnectivity of livestock markets is important. For instance, if there is an outbreak in Tanzania, 
would Kenya continue to export its livestock? This is a compelling reason to have a regional RVF 
framework or strategy, especially because of the porous borders. It would be in the common interest of 
the countries to address the disease jointly. 
• Intermittent vaccination can be carried out every three years for cattle and camels. A recombinant 
vaccine could increase uptake of the vaccines although it may not fully solve the problem of low uptake. 
• There is need for clear objectives to enable us to move forward with defined activities. 
• The strategy of intermittent vaccination requires discussion to identify suitable options for 
implementation. 
• Integration of the risk map with infection phases is good as it recognizes the need to conserve resources 
without compromising on effectiveness. 
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• Camels as target species in the vaccination strategies were only mentioned by one group. Probably this 
is because no data currently exists on vaccination of camels. It is important that they are factored in, 
although no suggestions were made on whether this should be adopted. 
• Gender-related challenges need to be mapped out to identify entry points for follow up as well as 
incentives and effects.  
 
Question: How practical is animal identification, considering that outbreaks happen in remote regions?  
Answer: The suggestion is that simple approaches be used, for example, notching as is done for rinderpest. 
However, the challenge is whether communities will accept to have their animals notched as this may affect the 




Enabling environment, institutional arrangements and 
requisite capacities 
 
Discussions on the establishment of an enabling environment, institutional arrangements and requisite 
capacities for the implementation of a regional RVF vaccination framework were carried out in the same groups 
used to discuss the design of RVF vaccination strategies. The following questions guided the group discussions: 
• What are the policies and legal frameworks needed to establish an enabling environment for 
implementing an effective and efficient RVF vaccination framework in East Africa? 
• What incentives are needed to promote participation by the public and private sectors in the 
implementation of an effective and efficient RVF vaccination framework in East Africa? 
• What institutions and institutional arrangements are needed to implement an effective and 
efficient RVF vaccination framework in East Africa? 
• What are the key stakeholder categories and their requisite capacity needs for implementing an 
effective and efficient RVF vaccination framework in East Africa? 
 
After the deliberations, reports from the three groups were presented and discussed in plenary. Since the three 
groups responded to the same guiding questions, their reports were then harmonized and summarized into one 
report that incorporates the plenary feedback as outlined below. 
 
Establishment of an enabling environment 
The following were identified as the policy and legal frameworks needed to establish an enabling environment 
for implementing an effective RVF vaccination framework in East Africa: 
• At the IGAD level: IGAD supports the control of trade-sensitive diseases in the region, recognizes RVF 
as a priority animal disease and supports regional animal health networks such as the Eastern Africa 
Regional Laboratory Network and the Eastern Africa Regional Epidemiology Network. IGAD, however, 
needs to set up a sub-network for RVF alongside existing networks, promote a regional One Health 
approach and put in place a strategy for control of transboundary animal diseases. 
• At the EAC level: EAC recognizes RVF as a priority disease. Policies at EAC level exist but their 
implementation needs to be strengthened. Disease control coordination instruments are also in place; 
these instruments refer to transboundary animal diseases, zoonoses and a contingency plan. There is, 
however, need to implement the existing policies, establish a regional zoonotic disease/One Health 
office and establish a sub-network for RVF. 
• Required policies and legal frameworks: There is a need to establish appropriate policies to guide the 
use of vaccines across borders, disease reporting and notification, and standardization. In addition, 
there is a need for appropriate legal frameworks for disease control and vaccination in each country, a 
preparedness and response plan and a memorandum of understanding among member countries. 
Currently, there are memoranda of understanding for transboundary animal diseases. There is a need to 
harmonize disease control policies, legal frameworks and strategies in the region; initially, this will 
require a review of existing policies and legal frameworks in the member countries. 
• Policy and legislative issues that need to be addressed:  
o The existence of an Animal Disease Act is a useful overarching document for each country 
o A harmonized policy for registration of vaccines such as Smithburn® and Clone 13 that are 
already available 
o A policy for the use of drones to deliver vaccines during flooding; this should consider cost-
effectiveness, cold chain storage and availability of technical staff to administer the vaccine 
o A policy to address animal identification and traceability 
o Formulation and enforcement of relevant laws pertaining to One Health 
o Policy/legal framework on animal movement, and its implications 
• Other issues that need to be addressed:  
o Shortage of veterinary services in pastoralist communities 
o Records of previous vaccination, considering the lack of a disease control policy in some 
countries 
o Identification of regions at risk and development of a regional risk map 
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o Contingency plans for RVF control 
o Enhanced funding within countries 
 
Incentives to promote public and private sector participation 
RVF control is more of a public than a private good. Benefits are realized when livelihoods are improved through 
better markets for livestock, leading to better incomes. The following were identified as the incentives needed to 
promote public and private sector participation in the implementation of an effective and efficient RVF 
vaccination framework in East Africa: 
• Offering tax reliefs for companies such as beef exporters that contribute to vaccination 
• Compensating farmers for losses accruing from the use of vaccines 
• Providing subsidies on vaccines to lower the costs borne by farmers 
• Contractual collaborations to address the shortage of professionals 
• Mobilization and use of centralized resources 
• Involving farmers, local communities and farmer associations 
• Sensitization and training of local groups to create awareness among communities 
• Understanding the local communities and addressing their knowledge and information needs 
• Combining vaccination and free health check-ups for livestock and complimentary treatment during 
vaccinations 
• Contracting private-sector practitioners with the requisite expertise and training to diagnose, treat and 
report back to the government 
• Coordinated joint regional vaccination campaigns through RVF sub-networks 
• Establishment of disease-free zones 
• Facilitated market access (local, cross-country and regional) for vaccinated livestock by regional 
economic communities, governments and partners 
• Strengthening of public education and extension services 
 
Institutions and institutional arrangements  
The following were identified as the institutions that have a role to play in the implementation of an effective 
and efficient RVF vaccination framework in East Africa: 
• Ministries of livestock 
• Departments of veterinary services 
• Vaccine production institutions 
• Diagnostic institutions 
• Ministries of health 
• Research institutions 
• Private animal health service providers 
• Livestock producers 
• Regional economic communities 
• Livestock producer associations 
• Regional and international organizations such as FAO, OIE, WHO and AU-IBAR 
• Livestock marketing associations 
• Devolved governance units (national and local administration) 
 
The following were identified as the required institutional arrangements:  
• Establishment of a coordination committee: identify the strengths of each institution and linkages 
among them; identify what the institutions do and group those with similar activities 
• Cross-institutional arrangements linking research, diagnostics and dissemination personnel, including 
training of field personnel and financial allocation to manage the cross-institutional arrangements 
• Zoonotic Disease Unit technical working group 
• International training organizations to provide standardized training and capacity building 
• East Africa RVF committee; national RVF committees within each country; working groups at county 
levels and local communities 




• Suggested membership of the national RVF committees in Kenya, Tanzania and Uganda: ministries of 
livestock, FAO, WHO, OIE, research institutions, meteorological departments, diagnostic laboratories, 
representatives from county governments, and PANVAC 
 
Key stakeholder categories and their capacity requirements 
Table 2 summarises the key stakeholder categories and their requisite capacity needs for implementing an 
effective and efficient RVF vaccination framework in East Africa. 
 
Table 2: Key stakeholder categories and their capacity requirements 
Key stakeholder category Capacity requirements 
Relevant ministries Personnel, equipment, vehicles, cold chain 
Information and data collection, analysis and sharing 
Formulation and enforcement of policy and legal framework  
State and county veterinary departments Human and financial resources 
Communication and advocacy 
Infrastructure and facilities 
Administration and other logistical support to the department 
Provincial administration Awareness creation  
Human and financial resources 
Ground logistics 
Security 
Research institutions  Expertise in technology and innovation development 
Research infrastructure and other facilities 
Human and financial resources 
Technical expertise 
Extension divisions Expertise in technology and innovation dissemination 
Human and financial resources 
Communication and advocacy  
Capacity building and training 
Training and research institutions Expertise in technology development  
Research and training infrastructure and facilities 
Specialized training 
Vaccine manufacturers Technical expertise 
Human and financial resources 
Expansion of production units 
Investment in new technologies  
Stockpiling of vaccines 
Production of vaccines at short notice 
Livestock producer and marketing 
associations  
Awareness creation 
Knowledge on disease recognition and reporting 
Market requirements 
Private animal health service providers  Knowledge on disease recognition 
Vaccination infrastructure and facilities (cold chain, equipment) 
Registration by professional bodies  
Meteorological departments Human and financial resources and facilities to undertake regular 
and accurate weather and climate predictions 
Communication of regular and accurate information on changes in 
weather and climate 
Technical organizations  
(WHO, FAO, OIE, Africa CDC and AU-IBAR)  
Expertise to develop the policy framework  
Improved linkages among themselves and with countries 
Technical expertise  
Regional economic communities  Formulation of a regional policy and legal framework  
Expertise to develop the policy framework  
Coordination, monitoring and evaluation 
Development partners Policy orientation 
Technical expertise 
Media Communications and information sharing 
















Workshop closing remarks and evaluation 
 
Closing remarks 
Antony M. Kilewe, Topridas Consultancy Services  
He said that he had enjoyed facilitating the workshop and hoped that it had delivered on the expected outputs 
and that the facilitators’ performance met both the participants’ and the organizers’ expectations. He thanked 
the ILRI management for the opportunity to facilitate the workshop; Bernard Bett for his valuable guidance, 
advice and encouragement in preparing and conducting the workshop; the participants for their dedication and 
commitment which made the facilitation task easy and enjoyable; Sarah Ndung’u of ILRI and the rest of the 
organizing team for the excellent handling of the logistics before and during the workshop; and the management 
of Lake Naivasha Country Club for providing excellent facilities and services. He concluded his remarks by 
wishing everybody a safe journey to their respective destinations and said he looked forward to continued 
cooperation and collaboration in similar future activities. He then invited Bernard Bett to proceed with the 
remaining part of the workshop closing protocol. 
 
Bernard Bett, ILRI 
He thanked the participants for their dedication and commitment during the workshop. He also thanked Dr 
Murithi, a private citizen, who found time to attend the workshop. He said the workshop report would be shared 
and the presentations made available via an online link. He was grateful for the good discussions on economic 
analysis that provided insights into viable options and said that follow-up discussions would be held on the 
ideas generated during the workshop and individual countries would be consulted to identify activities that can 
be undertaken. He also thanked the Director of Veterinary Services for finding time to join the workshop for the 
closing session. He then invited Rosemary Sang, Samuel Amwayi and Harry Oyas to make some remarks about 
the workshop and requested Harry Oyas to conclude his remarks by inviting the Director of Veterinary Services 
to make the final closing remarks. 
 
Rosemary Sang, KEMRI 
She thanked Bernard Bett and the ILRI management for the invitation to the workshop and said that it was a 
good learning opportunity and she had learnt a lot. She said that despite the efforts being made in control of 
RVF, the issue of vector control seems to be neglected and hoped that it would be given greater emphasis in 
future. She concluded by thanking all participants and said she hoped they would meet again. 
 
Samuel Amwayi, Ministry of Health 
He thanked all for sparing time to attend the workshop. He said he was the only representative from the 
Ministry of Health and was impressed with the efforts that the DVS had put into this initiative. He recalled the 
One Health initiative after the 2007 RVF outbreak where there was impressive input from the ministry. This 
effort, he said, had waned over the years and there is a need to revive it so that the ministry can benefit from 
such exchanges of information. He said sharing of information is critical among partners as it enhances 
understanding of the problem and enables parties to prepare to mitigate appropriately. Such initiatives are 
beneficial because, at the end of the day, it is to the advantage of the human population. He assured the 
participants of the ministry’s support, thanked them and wished them a safe journey. 
 
Harry Oyas, DVS 
He thanked all and said he was pleased with the achievements of the workshop, having participated in the 
initiative and as part of the DVS. He said his presentation covered the strategies Kenya had adopted and which 
the government has been implementing for a long time. This workshop had, however, presented a more 
scientific approach to vaccination that is workable and agreeable to the three countries. He assured ILRI of the 
support of the DVS in the implementation of the project. He then invited the Director of Veterinary Services, 
Obadiah Njagi, to give the final workshop closing remarks. 
 
Obadiah Njagi, DVS 
He thanked the participants for their commitment to the workshop and said he was grateful to be back to make 
the closing remarks. He said the DVS was keen to work on this initiative among others and assured the project of 
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the directorate’s support in the implementation. He said the directorate could no longer take for granted the 
support and goodwill of donors and, therefore, must ensure that initiatives are actualized. Development partners 
are making available resources to complement what the government provides and there is need to take 
advantage of this support and ensure initiatives are coordinated. 
 
He said he was aware of several initiatives dealing with RVF whose impact is yet to be felt and that the ministry 
is streamlining their implementation to avoid overlaps and duplication of activities. He said this was a good 
initiative and hoped the next step would include discussions with the county governments because they are the 
implementers at the grassroots. He said the DVS has developed a platform that has been successful so far and 
this initiative can take advantage of it. He thanked all for finding time to participate and encouraged them to 
visit some of the nearby tourist sites. He concluded by wishing all a safe journey home and then declared the 
workshop officially closed. 
 
Evaluation 
The participants (in group formation) were requested to take a few minutes to evaluate the workshop by 
completing a simple evaluation form that required the participants to rate the workshop in general, attainment 
of the workshop purpose, attainment of the expected workshop outputs, workshop facilitation and the main 
features of the workshop on a scale of very good, good, average and poor. The feedback provided by the 
participants will be used to improve the planning, organization and management of future workshops. A total of 
three groups completed and returned the evaluation forms. The analysis of the responses indicated that the 
workshop was quite successful with an overall rating of 45% very good and 55% good. 
 
The most mentioned aspects of the workshop that the participants thought went well were as follows:  
• Very good adherence to the workshop agenda 
• Successful collection of the required information 
• Good group discussion sessions with clear terms of reference 
• Very good workshop facilitation and good time management 
• A good mix of the workshop participants and presentations 
• Good pre-workshop preparations and communication 
 
The most mentioned aspects that the participants thought needed improvement were as follows:  
• Facilities in the conference hall, particularly the flickering light in the hall 
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Name Email Designation/Organization 
Absolomon Kihara wangoru.kihara@badili.co.ke Director, Badili Innovations 
Antony M. Kilewe kilewe@topridasconsultancy.co.ke Consultant, Topridas Consultancy Services 
Bernard Bett b.bett@cgiar.org Scientist, ILRI 
Catherine Karungo drcatherinekarungo@gmail.com Graduate assistant, Moi University 
Dan Tumusiime drdantumusiime@gmail.com Senior veterinary officer 
Delia Grace d.grace@cgiar.org Scientist, ILRI 
Fausta Mosha fausta_mosha@yahoo.com Laboratory consultant 
Francis Wanyoike f.wanyoike@cgiar.org Research associate, ILRI 
George Njogu njoroge2003@yahoo.com Veterinary epidemiologist 
George Warimwe gwarimwe@kemri-wellcome.org Immunologist, KEMRI Wellcome Trust Research Program 
Harry Oyas harryoyas@yahoo.com Deputy director, DVS, Kenya 
Jones Mutua drmutuajones@gmail.com Senior production officer, KEVEVAPI 
Joseph Njuguna joseph.njuguna@fao.org National livestock officer, FAO 
Josephine Namayanja namayanjajosephine@gmail.com Veterinary epidemiologist 
John Gachohi john.gachohi@wsu.edu Postdoctoral fellow, Washington State University 
Johanna Lindahl j.lindahl@cgiar.org Scientist, ILRI 
Kariuki Njenga knjenga@vetmed.wsu Director, Washington State University 
Madeleine Clark madeleine.clark@pirbright.ac.uk Epidemiologist 
Mathew Kungu muturimathew@gmail.com Veterinary epidemiologist 
Nicholas Svitek n.svitek@cgiar.org Scientist, ILRI 
Nicoline de Han n.dehaan@cgiar.org Scientist, ILRI 
Obadiah Njagi jesse.mwere@gmail.com Director, DVS, Kenya 
Rees Mbabu murithi.mbabu@gmail.com Animal health expert 
Rosemary Sang Rosemary.sang@vsmru-k.org KEMRI 
Salome Bukachi sallybukachi@yahoo.com University of Nairobi 
Sam Okuthe sam.okuthe@fao.org Epidemiologist, FAO  
Samuel Amwayi samwayi2016@gmail.com Ministry of Health 





Annex 2: Workshop program 
 
Wednesday 4 October 2017 
Time Activity Responsible 
08:00–08:30 Registration and review of documents ILRI/facilitators 
SESSION 1 Workshop opening and scene setting 
08:30–08:40 Introductions and workshop approach Facilitators 
08:40–08:50 Workshop purpose and expected outputs Bernard Bett  
08:50–09:00 Welcome remarks Iain Wright 
09:00–09:30 Workshop opening remarks Chief Veterinary Officer, Kenya 
SESSION 2 Project strategic focus and implementation arrangements 
09:30–09:40 Overview of the project Bernard Bett 
09:40–09:55 Immune response studies (field and laboratory) Nicholas Svitek 
09:55–10:10 Gender and RVF vaccination Salome Bukachi 
10:10–10:25 Decision support framework electronic platform  Absolomon Kihara 
10:25–10:50 Plenary discussion on the presentations Facilitators 
10:50–11:20 HEALTH BREAK AND GROUP PHOTOGRAPH 
SESSION 3 Background review of RVF control policies in East Africa 
11:20–11:35 RVF report: Kenya Harry Oyas 
11:35–11:50 RVF report: Uganda Dan Tumusiime 
11:50–12:05 RVF report: Tanzania Fausta Mosha 
12:05–12:20 FAO’s RVF-related activities in the region Folorunso Fasina 
SESSION 4 RVF vaccine development 
12:20– 12:35 Validation of Clone 13 RVF vaccine in Kenya Kariuki Njenga 
12:35–12:50 Development of new vaccines George Warimwe 
12:50–13:30 Plenary discussion  Facilitators 
13:30–14:30 LUNCH 
SESSION 5 Design of RVF vaccination strategies and their implementation processes 
14:30–14:40 Discussion group formation, terms of reference and task 
assignment 
Kariuki Njenga 
14:40–16:00 Group-based discussions as per the terms of reference Group chairpersons; facilitators 
16:00–16:30 HEALTH BREAK 
16:30– 17:30 Group-based discussions as per the terms of reference (continued) Group chairpersons; facilitators 
17:30 Review of Session 5  Facilitators  
 
Thursday 5 October 2017 
SESSION 5 Design of RVF vaccination strategies and their implementation processes (continued) 
08:30–08:40 Recap on day one and emerging issues Facilitators 
08:40–10:00 Plenary presentation, discussion and consensus building on group 
reports 
Group rapporteurs; facilitators 
10:00–10:30 HEALTH BREAK 
SESSION 6 RVF vaccination framework enabling environment, institutional arrangements, requisite capacities  
10:30–10:40 Discussion group formation, terms of reference and task 
assignment 
Bernard Bett 
10:40–12:30 Group-based discussions as per the terms of reference Group rapporteurs; facilitators 
12:30–14:00 LUNCH 
14:00–15:00 Plenary presentation, discussion and consensus building on group 
reports 
Group rapporteurs; facilitators 
SESSION 7 Way forward, workshop evaluation and closing remarks 
15:00–15:20 Way forward ILRI/facilitators 
15:20–16:00 Closing remarks and evaluation DVS; Delia Grace; Josephine Namayanja 
16:00–16:30 HEALTH BREAK  
 End of workshop and departure 
 
